Picture of Cardiff Oncology logo

CRDF — Cardiff Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Cardiff Oncology Inc reports results for the quarter ended in September 30 - Earnings Summary

* Cardiff Oncology Inc  CRDF.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -22 cents.  The mean expectation of five analysts for the
quarter was for a loss of 27 cents per share. Wall Street
expected results to range from -29 cents to -26 cents per share.
    * Revenue rose 17% to $165.00 thousand from a year ago;
analysts
expected $80.00 thousand. 
    * Cardiff Oncology Inc's reported EPS for the quarter was a
loss
of 25 cents​.
    * The company reported a quarterly loss of $11.86 million.
    * Cardiff Oncology Inc shares had risen by 42.7% this
quarter and
gained 157.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Cardiff Oncology
Inc is $8.00 
This summary was machine generated from LSEG data November 8 at
05:05 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.27          -0.25          Beat
 Jun. 30 2024      -0.25          -0.26          Missed
 Mar. 31 2024                     -0.22          
 Dec. 31 2023      -0.28          -0.21          Beat

Recent news on Cardiff Oncology

See all news